These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 19483405

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipients.
    Allinson K, Kolve H, Gumbinger HG, Vormoor HJ, Ehlert K, Groll AH.
    J Antimicrob Chemother; 2008 Mar; 61(3):734-42. PubMed ID: 18238891
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
    Mikulska M, Raiola AM, Bruno B, Furfaro E, Van Lint MT, Bregante S, Ibatici A, Del Bono V, Bacigalupo A, Viscoli C.
    Bone Marrow Transplant; 2009 Sep; 44(6):361-70. PubMed ID: 19308042
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Donor peripheral hematopoietic stem cells infusion for prophylaxis of relapse of high risk leukemia after allogeneic hematopoietic stem cell transplantation].
    Liu DH, Huang XJ, Chen H, Xu LP, Liu KY, Han W, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):6-9. PubMed ID: 16732930
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
    You Y, Li QB, Chen ZC, Li WM, Xia LH, Zhou H, Zou P.
    Chin Med J (Engl); 2008 Sep 20; 121(18):1770-4. PubMed ID: 19080355
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis.
    Siwek GT, Pfaller MA, Polgreen PM, Cobb S, Hoth P, Magalheas-Silverman M, Diekema DJ.
    Diagn Microbiol Infect Dis; 2006 Jul 20; 55(3):209-12. PubMed ID: 16626917
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Living-donor lobar lung transplantation for pulmonary complications after hematopoietic stem cell transplantation.
    Yamane M, Sano Y, Toyooka S, Okazaki M, Date H, Oto T.
    Transplantation; 2008 Dec 27; 86(12):1767-70. PubMed ID: 19104419
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA).
    Ito JI, Chandrasekar PH, Hooshmand-Rad R.
    Bone Marrow Transplant; 2005 Nov 27; 36(10):873-7. PubMed ID: 16113663
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.